Connect with us

Hi, what are you looking for?

There are no plans to tests COVID-19 Vaccine on Kwnyns: President

Capital Health

Uhuru says no plans to conduct COVID-19 vaccine trials in Kenya

NAIROBI, Kenya Apr 26 – President Uhuru Kenyatta says Kenya Medical Research Institute (KEMRI) and Primate Research Institute are involved in global efforts to develop coronavirus vaccine, dismissing reports of COVID-19 vaccine tests in Kenya by Oxford University.

BBC had reported that Oxford University researchers were considering testing their vaccines on Kenyans due to the lower transmission rates in the region, an issue which sparked outrage among a section of Kenyans.

Fergus Walsh, a medical correspondent at BBC had said the Oxford team were planning to launch the tests in the country if it will not get quick results with ongoing trials in the United Kingdom.

Nonetheless, the President dismissed these reports saying “there are those saying that research is ongoing where Kenyans are being used as guinea pigs for vaccine tests, there are no truths to such allegations.”

He said research institutes in the country are working on a similar project to find a cure for COVID-19 which has so far infected 343  and claimed 14 lives in the country.

The President assured that his Government would notify Kenyans in case of any plans to conduct the vaccine tests in the country.

 “Kenya Medical Research Institute (KEMRI) and Primate Research Institute are involved in a global effort to try and find a vaccine and once we have found one and have reached an area where this vaccine can be tested on humans, we shall let you know, nothing will be kept in the dark,” he assured.

The Ministry of Health Friday had denied knowledge of plans by Oxford University researchers to conduct the vaccine trials in Kenya.

Advertisement. Scroll to continue reading.
President Kenyatta has dismissed reports that global vaccine firms were planning to test them on Kenyas.

“There are vigorous procedures of ethical review and approach of any clinical trials and we have a robust structure under the Pharmacies and Poisons Board (PPB) that is responsible for regulating and reviewing clinical trials,” Amana said.

Oxford’s human trials for coronavirus vaccine begun in Europe with 800 volunteers recruited for the study. The Oxford team is targeting 5,000 more recruits in the coming months.

Should the trials become effective, the scientists say a million vaccines will be ready by September.

Globally, there are nearly 3 million infections with almost 200,000 deaths and more than 800,000 recoveries recorded.


More on Capital News